Product Wiki · Recalls · EU Safety Gate (RAPEX)

Jouet en peluche de Capybara de 22 cm/8,66 pouces- Nom figurant sur… — recall SR/00185/26

EU Safety Gate (RAPEX) · France · 2026-01-30 · Serious risk

As described by EU Safety Gate (RAPEX): Jouet en peluche de Capybara de 22 cm/8,66 pouces- Nom figurant sur l'emballage: Plush toys

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/00185/26
Date of alert
2026-01-30
Country / jurisdiction
France
Risk level
Serious risk
Risk type
Choking, Strangulation
Product category
Toys
Product type
Plush toy
🔴 Serious hazard — Reported risk: The fibrous stuffing material of the toy is easily accessible. A small child could put stuffing material in the mouth and choke. Moreover, the loop of the mask could become trapped around the neck of the child, leading to strangulation.
Action taken by the authority
Type of economic operator taking notified measure
Other
Category of measure
Warning consumers of the risks
Date of entry into force
28/04/2024
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Jouet en peluche de Capybara de 22 cm/8,66 pouces- Nom figurant sur l'emballage: Plush toys

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10097221

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.